2023-10-25 20:59:01
New data from a clinical trial in Japan suggests that an antiviral pill called ensitrelvir shortens the duration of two of the most characteristic symptoms of COVID-19: the loss of smell and of gusto.
When the pandemic began, approximately between 40% and 50% of people with COVID-19 experienced altered smell and taste. The antiviral medication speeds up the recovery of these senses, according to researchers.
In Japan received the approval last year and the drug is available for people with symptoms ranging from light a moderateregardless of their risk factors, as explained by Nature.
Your developer, Shionogi, in Osaka, continues to conduct clinical trials of the drug, which have not yet been approved outside of Japan. It was in one of those studies where, by providing him with 125 a 250 milligrams of ensitrelvir or a placebo to people with mild COVID-19 symptoms, they observed that the percentage of participants with loss of smell and taste had decreased reduced a week a 39% regarding the beginning.
Related news
“Most people eventually recover on their own, but we know that some people have had long-term problems with smell and taste”dice Yohei Doian infectious disease researcher at Fujita Health University in Toyoake and one of the study’s researchers.
Smell and taste problems are less common now than in the early stages of the pandemic. “When Omicron variants became dominant, loss of taste and smell began to become less and less common”dice Amesh Adaljaan infectious disease specialist at the Johns Hopkins Center for Health Security in Baltimore.
#pill #helps #recover #smell #taste #covid